Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?

Valued at a market cap of $194.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of healthcare products across various segments. With operations in pharmaceuticals, diagnostics, nutrition, and medical devices, it serves diverse markets worldwide, including emerging and developed regions.

Companies worth over $10 billion are generally described as “large-cap” stocks, and Abbott Laboratories fits this criterion perfectly. Abbott is renowned for its innovative medical devices, particularly the FreeStyle Libre continuous glucose monitoring system, which revolutionized diabetes care.